Skip to Content
Last Updated: 11/04/14

caHUB Development

Overview

The National Cancer Institute (NCI) is developing the cancer Human Biobank (caHUB) through a phased implementation over the next few years (see timeline). The ultimate goal is to establish caHUB as a robust public-private partnership between NCI, other government agencies, academic biomedical research institutions, cancer centers, and industry participants.

During the initial planning phase, caHUB operational/business unit planning subgroups at NCI are developing goals, objectives, and deliverables.

caHUB Planning Subgroups

  1. Acquisition of Normal Tissues
  2. Biospecimens
  3. Communication and Marketing
  4. Ethical, Legal, and Social Issues
  5. Facilities
  6. Informatics and Data Management
  7. Partnerships
  8. Strategic Planning and Organizational Structures

Once the subgroups’ action plans are completed, work will start in Phase 1 on the structure for caHUB, including development of the more mature functions of this national resource.

During Phase 2, NCI envisions the implementation of the caHUB private-public partnership, which will:

  • Build public trust
  • Share risks between the public (government) and private sectors
  • Provide greater operating flexibility
  • Generate commercial uses that will translate discoveries to the marketplace as drugs or diagnostics for cancer